Crossover comparison maximum dose glyburide glipizide Patients non-insulin-dependent diabetes NIDDM maximum dose glyburide GB glipizide GZ trial alternate second-generation sulfonylurea SGS insulin therapy efficacy therapeutic maneuver subjects serum glucose FSG levels mmol/L mg/dL maximum doses GB mg/day GZ mg/day Group subjects GB mean FSG mmol/L mg/dL group subjects GZ mean FSG mmol/L mg/dL Subjects original SGS weeks maximum dose alternate agent additional weeks Values FSG hemoglobin lipids study weeks SGS trial significant changes variable group maximum dose GB therapy dose GZ therapy combined study group advantage agent metabolic control NIDDM patients maximum dose GB GZ alternate SGS 